Author: CapitalGainsFund

May 31

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS with TEV-‘749 (olanzapine) to Date

About SchizophreniaSchizophrenia is a chronic, progressive and severely debilitating mental disorder that affects how one thinks, feels and acts.3 Patients experience an array of symptoms, which may include delusions, hallucinations, disorganized speech or behavior and impaired cognitive ability.3,4,5 Approximately 1% of the world’s population will develop schizophrenia in their lifetime, and 3.5 million people in the U.S. are […]
May 31

EverGen Infrastructure Reports Q1 2025 Results

This news release contains certain forward-looking statements and/or forward-looking information (collectively, “forward looking statements”) within the meaning of applicable securities laws. When used in this release, such words as “would”, “will”, “anticipates”, “believes“, ”explores“, ”expects“ and similar expressions, as they relate to EverGen, or its management, are intended to identify such forward-looking statements. More particularly, […]
May 30

Starlink set to expand UK footprint as Ofcom greenlights new spectrum licences

Elon Musk’s Starlink is on track to play a larger role in the UK’s broadband infrastructure, with telecoms regulator Ofcom proposing new temporary spectrum licences to expand the satellite internet provider’s capacity across the country. Under the plans, Starlink would gain access to additional E band frequencies at three of its existing ground stations in […]